It is available for people with weight-related health problems with: A BMI of 35 or more, or 32.5 or more for people of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin
Most likely reality: microdoses produce small metabolic improvements - subtle visceral fat changes, modest improvements in insulin sensitivity, minor reductions in inflammatory signaling - that compound over time into meaningful clinical benefits
If your order ships correctly and your questions get answered, youre likely to rave about the value
The science says no
Patients in the clinical trials, who all have diabetes and/or obesity, also had fewer complaints about nausea and diarrhea
Orland said the most important takeaway is that the drugs appear to be safe to use for diabetes or weight loss in people undergoing cancer treatment, though its still too soon to recommend GLP-1s for any type of cancer therapy.